DNA molecules encoding human HELA2 or testisin serine proteinases
US6479274B1 · kind B1 · utility
10Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 1998 |
| Grant date | Nov 12, 2002 |
| Priority date | — |
| Expiry date | Feb 13, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention related generally to novel molecules and more particularly novel proteinaceous molecules involved in or associated with regulation of cell activities and/or viability. The present invention is particularly directed to novel serine proteinases and a novel kinase and to derivatives, agonists and antagonists thereof. In one embodiment, the present invention provides a novel serine proteinase, referred to herein as “HELA2” or “testisin”, which has roles in spermatogenesis, in suppressing testicular cancer and as a marker for cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.